AT372279B - METHOD FOR PRODUCING GALENIC PREPARATIONS - Google Patents
METHOD FOR PRODUCING GALENIC PREPARATIONSInfo
- Publication number
- AT372279B AT372279B AT0803679A AT803679A AT372279B AT 372279 B AT372279 B AT 372279B AT 0803679 A AT0803679 A AT 0803679A AT 803679 A AT803679 A AT 803679A AT 372279 B AT372279 B AT 372279B
- Authority
- AT
- Austria
- Prior art keywords
- galenic preparations
- producing
- producing galenic
- preparations
- galenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1302178 | 1978-12-21 | ||
CH1301978 | 1978-12-21 | ||
CH56679 | 1979-01-19 | ||
CH56779 | 1979-01-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA803679A ATA803679A (en) | 1983-02-15 |
AT372279B true AT372279B (en) | 1983-09-26 |
Family
ID=27427929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0803679A AT372279B (en) | 1978-12-21 | 1979-12-20 | METHOD FOR PRODUCING GALENIC PREPARATIONS |
Country Status (23)
Country | Link |
---|---|
AT (1) | AT372279B (en) |
AU (1) | AU534051B2 (en) |
CA (1) | CA1139222A (en) |
CH (1) | CH642259A5 (en) |
CY (1) | CY1330A (en) |
DE (1) | DE2950154A1 (en) |
DK (1) | DK154607C (en) |
FI (1) | FI793888A (en) |
FR (1) | FR2444463A1 (en) |
GB (1) | GB2038181B (en) |
HK (1) | HK37986A (en) |
HU (1) | HU182577B (en) |
IE (1) | IE49323B1 (en) |
IL (1) | IL59003A (en) |
IT (1) | IT1164029B (en) |
KE (1) | KE3617D (en) |
MY (1) | MY8500129A (en) |
NL (1) | NL187229C (en) |
NZ (1) | NZ192457A (en) |
PH (1) | PH25178A (en) |
PT (1) | PT70614A (en) |
SE (1) | SE442265B (en) |
WO (1) | WO1980001242A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT388101B (en) * | 1985-02-05 | 1989-05-10 | Sandoz Ag | Process for the production of a pharmaceutical composition for oral administration with controlled release of active ingredient |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0064485B1 (en) * | 1981-04-27 | 1985-07-24 | Aktiebolaget Hässle | New pharmaceutical preparation |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
HU192050B (en) * | 1983-04-22 | 1987-05-28 | Sandoz Ag | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist |
DE3413955A1 (en) * | 1983-04-22 | 1984-10-25 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmaceutical product containing co-dergocrine and a calcium antagonist |
NL194389C (en) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Process for preparing a solid dispersion of a pharmaceutically active agent that has low water solubility in a solid matrix of a water-soluble polyalkylene glycol as a carrier. |
GB8426922D0 (en) * | 1984-10-24 | 1984-11-28 | Sandoz Ltd | Galenic formulation |
CN1003978B (en) * | 1987-09-05 | 1989-04-26 | 广州陈李济药厂 | Preparation process of spleen-tonifying and intestine-benefiting pills |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
DE2528257C2 (en) * | 1974-07-04 | 1986-02-13 | Sandoz-Patent-GmbH, 7850 Lörrach | New galenic preparation |
DE2546577B2 (en) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Solid substances made from polyvinylpyrrolidone and ergot alkaloids |
-
1979
- 1979-12-12 CH CH626380A patent/CH642259A5/en not_active IP Right Cessation
- 1979-12-12 SE SE7910227A patent/SE442265B/en not_active IP Right Cessation
- 1979-12-12 WO PCT/CH1979/000160 patent/WO1980001242A1/en unknown
- 1979-12-12 FI FI793888A patent/FI793888A/en not_active Application Discontinuation
- 1979-12-12 DK DK529879A patent/DK154607C/en not_active IP Right Cessation
- 1979-12-13 DE DE19792950154 patent/DE2950154A1/en active Granted
- 1979-12-18 NL NLAANVRAGE7909105,A patent/NL187229C/en not_active IP Right Cessation
- 1979-12-19 IL IL59003A patent/IL59003A/en unknown
- 1979-12-19 PH PH23436A patent/PH25178A/en unknown
- 1979-12-19 CA CA000342212A patent/CA1139222A/en not_active Expired
- 1979-12-19 NZ NZ192457A patent/NZ192457A/en unknown
- 1979-12-19 AU AU54031/79A patent/AU534051B2/en not_active Ceased
- 1979-12-19 PT PT70614A patent/PT70614A/en not_active IP Right Cessation
- 1979-12-19 IE IE2471/79A patent/IE49323B1/en unknown
- 1979-12-19 CY CY1330A patent/CY1330A/en unknown
- 1979-12-19 GB GB7943633A patent/GB2038181B/en not_active Expired
- 1979-12-20 FR FR7931229A patent/FR2444463A1/en active Granted
- 1979-12-20 AT AT0803679A patent/AT372279B/en active
- 1979-12-20 IT IT51153/79A patent/IT1164029B/en active
- 1979-12-20 HU HU79SA3216A patent/HU182577B/en not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY129/85A patent/MY8500129A/en unknown
-
1986
- 1986-03-18 KE KE3617BD patent/KE3617D/en unknown
- 1986-05-22 HK HK379/86A patent/HK37986A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT388101B (en) * | 1985-02-05 | 1989-05-10 | Sandoz Ag | Process for the production of a pharmaceutical composition for oral administration with controlled release of active ingredient |
Also Published As
Publication number | Publication date |
---|---|
DK529879A (en) | 1980-06-22 |
FR2444463A1 (en) | 1980-07-18 |
GB2038181A (en) | 1980-07-23 |
NL187229C (en) | 1991-07-16 |
GB2038181B (en) | 1983-05-11 |
IT1164029B (en) | 1987-04-08 |
DK154607B (en) | 1988-12-05 |
AU534051B2 (en) | 1984-01-05 |
DE2950154C2 (en) | 1989-05-11 |
IE792471L (en) | 1980-06-21 |
SE7910227L (en) | 1980-06-22 |
HK37986A (en) | 1986-05-30 |
SE442265B (en) | 1985-12-16 |
IL59003A (en) | 1982-12-31 |
DE2950154A1 (en) | 1980-07-10 |
PT70614A (en) | 1980-01-01 |
PH25178A (en) | 1991-03-27 |
WO1980001242A1 (en) | 1980-06-26 |
IT7951153A0 (en) | 1979-12-20 |
NZ192457A (en) | 1983-06-17 |
AU5403179A (en) | 1980-06-26 |
KE3617D (en) | 1986-04-18 |
IE49323B1 (en) | 1985-09-18 |
CY1330A (en) | 1986-06-27 |
DK154607C (en) | 1989-06-05 |
FI793888A (en) | 1980-06-22 |
MY8500129A (en) | 1985-12-31 |
CA1139222A (en) | 1983-01-11 |
FR2444463B1 (en) | 1983-02-25 |
HU182577B (en) | 1984-02-28 |
NL7909105A (en) | 1980-06-24 |
CH642259A5 (en) | 1984-04-13 |
ATA803679A (en) | 1983-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT364451B (en) | METHOD FOR PRODUCING LOCALANETHETICALLY EFFECTIVE COMBINATION PREPARATIONS | |
ATA729079A (en) | METHOD FOR PRODUCING MONALDEHYDES | |
AT369366B (en) | METHOD FOR PRODUCING LYSERGOL DERIVATIVES | |
AT371097B (en) | METHOD FOR PRODUCING O-METHALLYLOXYPHENOL | |
ATA311179A (en) | METHOD FOR PRODUCING 6ALPHA-HALOGEN -PREGNADIEN-DERIVATES | |
AT374486B (en) | METHOD FOR PRODUCING 17BETA-HYDROXY-17 | |
AT372279B (en) | METHOD FOR PRODUCING GALENIC PREPARATIONS | |
AT365452B (en) | METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS | |
AT380701B (en) | METHOD FOR PRODUCING MONOFILES | |
ATA663779A (en) | METHOD FOR PRODUCING 3-EXOMETHYL ENCEPHAMSULFOXIDESTERS | |
AT363186B (en) | METHOD FOR PRODUCING GLYCOSIDES | |
AT369728B (en) | METHOD FOR PRODUCING TRICHLORAETHYLENE | |
AT374399B (en) | METHOD FOR PRODUCING DRAWBORE | |
AT367017B (en) | METHOD FOR PRODUCING P-AMINO-DIPHENYLAMINE | |
AT369355B (en) | METHOD FOR PRODUCING 2'-DIAETHYLAMINO-1'METHYL [THYL-2-HYDROXY-2-CYCLOHEXYL OR -2-PHENYL-CYCLOHEXANCARBOXYLATE | |
AT372380B (en) | METHOD FOR PRODUCING 7-HYDROXYCUMARINE DERIVATIVES | |
AT371710B (en) | METHOD FOR PRODUCING GALENIC PREPARATIONS | |
AT376439B (en) | METHOD FOR PRODUCING ERGOTAL CALALID | |
AT370422B (en) | METHOD FOR PRODUCING VINDESINMONOSULFATE | |
DD136833A1 (en) | METHOD FOR PRODUCING POLYAETHERALCOOHOLES | |
ATA254579A (en) | METHOD FOR PRODUCING 2-MERCAPTOBENZTHIAZOL | |
AT357547B (en) | METHOD FOR PRODUCING 3-PHENYL-PYRIDAZONE- (6) | |
AT370759B (en) | METHOD FOR PRODUCING BITUMEN PREPARATIONS | |
ATA136279A (en) | METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS | |
AT366661B (en) | METHOD FOR PRODUCING CISBICYCLOOCTYLAMINES |